The DOI matches its Crossref record; 23 of the 27 references it cites were found in a registry or an index.
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Open accessAbstract
Abstract The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. Significance: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They are among the vulnerable groups because they are at higher risk of being infected and showing more severe symptoms and even death when infected.[13]”
From Psychological Distress of Breast Cancer Survivors During the COVID-19 Pandemic and Related Factors: A Controlled Study. (2023) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationCancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citationPathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,040
Flagged first, then by citations
4 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,001
Wang, Q., Li, L., Qu, T., Li, J., Wu, L., Li, K., Wang, Z., Zhu, M., Huang, B., Wu, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.644575 · Cited by 26
Self-citationComparison of COVID-19 outcomes among shielded and non-shielded populations
Jani, B., Ho, F. K. W., Lowe, D. J., Traynor, J. P., MacBride‐Stewart, S., Mark, P. B., Mair, F. S., & Pell, J. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-94630-6 · Cited by 24
Mileham, K. F., Bruinooge, S. S., Aggarwal, C., Patrick, A. L., Davis, C. W., Mesenhowski, D. J., Spira, A. I., Clayton, E. J., Waterhouse, D. M., Moore, S. G., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.21.00394 · Cited by 26
Management changes for patients with endocrine-related cancers in the COVID-19 pandemic
Raghavan, D., Tan, A. R., Story, E. S., Burgess, E. F., Musselwhite, L. W., Kim, E. S., & Clark, P. E. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0229 · Cited by 26
Chauhan, R., Trivedi, V., Rani, R., Singh, U., Singh, V., Shubham, S., Kumari, S., & Uniyal, A. (2020) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_255_20 · Cited by 25
Bersanelli, M., Giannarelli, D., Giorgi, U. D., Pignata, S., Maïo, M. D., Verzoni, E., Clemente, A., Guadalupi, V., Signorelli, D., Tiseo, M., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920968463 · Cited by 25
Peravali, M., Joshi, I., Ahn, J., & Kim, C. (2021) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2020.100141 · Cited by 25
COVID-19 vaccination in cancer patients: a narrative review
Seneviratne, S., Yasawardene, P., Wijerathne, W., & Somawardana, B. (2022) · Journal of International Medical Research · doi:10.1177/03000605221086155 · Cited by 18
Factors Associated With COVID-19 Death in the United States: Cohort Study
Chen, U., Xu, H., Krause, T. M., Greenberg, R. S., Dong, X., & Jiang, X. (2022) · JMIR Public Health and Surveillance · doi:10.2196/29343 · Cited by 25
Vaccine hesitancy in cancer patients: A rapid review
Butow, P. N., Shaw, J., Bartley, N., Milch, V., Sathiaraj, R., Turnbull, S., & Vartanian, C. D. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.107680 · Cited by 28
Identification of Clinical Features Associated with Mortality in COVID-19 Patients
Eskandarian, R., Alizadehsani, R., Behjati, M., Zahmatkesh, M., Sani, Z. A., Haddadi, A., Kakhi, K., Roshanzamir, M., Shoeibi, A., Hussain, S., et al. (2023) · Operations Research Forum · doi:10.1007/s43069-022-00191-3 · Cited by 25
Huang, S., Lai, H.-C., Lin, Y., Huang, W.-T., Hung, H.-H., Ou, S., Lin, H., & Hung, M. (2020) · PubMed Central · Cited by 24
Wang, B., & Huang, Y. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1824646 · Cited by 24
Relevance of the Bruton Tyrosine Kinase as a Target for COVID-19 Therapy
Rada, M., Qusairy, Z., Massip‐Salcedo, M., & Macip, S. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0814 · Cited by 24
Amatu, A., Pani, A., Patelli, G., Gagliardi, O. M., Loparco, M., Piscazzi, D., Cassingena, A., Tosi, F., Ghezzi, S., Campisi, D., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.12.006 · Cited by 24
Humoral response to mRNA ‐based COVID ‐19 vaccine in patients with myeloid malignancies
Mori, A., Onozawa, M., Tsukamoto, S., Ishio, T., Yokoyama, E., Izumiyama, K., Saito, M., Muraki, H., Morioka, M., Teshima, T., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18138 · Cited by 24
Parmar, A., Eskander, A. E., Sander, B., Naimark, D. M. J., Irish, J. C., & Chan, K. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.202380 · Cited by 27
Thrombosis, cancer, and COVID-19
Brito-Dellan, N., Tsoukalas, N., & Font, C. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07098-z · Cited by 24
Arayıcı, M. E., Kipcak, N., Kayacik, U., Kelbat, C., Keskin, D., Kilicarslan, M. E., Kilinc, A. V., Kirgoz, S., Kirilmaz, A., Kizilkaya, M. A., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04191-y · Cited by 24
Dai, M., Chen, Z., Leng, Y., Wu, M., Liu, Y., Zhou, F., Chen, M., Shao, N., Liu, M., & Cai, H. (2020) · Cancer Control · doi:10.1177/1073274820960467 · Cited by 24
Self-citationJavadinia, S. A., Ariamanesh, M., Nabavifard, M., Porouhan, P., PeyroShabany, B., Fazilat‐Panah, D., Hatami, F., Ghasemi, A., Lyman, G. H., Welsh, J. S., et al. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1995742 · Cited by 23
SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children
Liu, L., She, J., Yongqi, B., & Liu, W. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s313860 · Cited by 23
Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba
Decker, K., Lambert, P. J., Feely, A., Bucher, O., Kim, J. O., Hebbard, P. C., Thiessen, M. H., Fatoye, T., Pitz, M. W., Koul, R., et al. (2021) · Current Oncology · doi:10.3390/curroncol28040269 · Cited by 22
Strobel, S. B., Machiraju, D., Kälber, K. A., & Hassel, J. C. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03133-w · Cited by 23
War or peace: Viruses and metastasis
Bayat, M., Golestani, S., Motlaghzadeh, S., Baghi, H. B., Lalehzadeh, A., & Nahand, J. S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189179 · Cited by 23
Strategies and Advances in Combating COVID-19 in China
Liu, W. Y., Guan, W., & Zhong, N. (2020) · Engineering · doi:10.1016/j.eng.2020.10.003 · Cited by 23
Lyman, G. H., Kuderer, N. M., & Aapro, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697908 · Cited by 23
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS‐CoV‐2 Pandemic
Rossi, D., Shadman, M. S., Condoluci, A., Brown, J. R., Byrd, J. C., Gaïdano, G., Hallek, M. J., Hillmen, P., Mato, A. R., Montserrat, E., et al. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000432 · Cited by 22
Outcome of COVID‐19 in multiple myeloma patients in relation to treatment
Susek, K. H., Gran, C., Ljunggren, H., Alici, E., & Nahi, H. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13502 · Cited by 22
Virtual Cancer Care During the COVID-19 Pandemic and Beyond: A Call for Evaluation
Levine, O. H., McGillion, M. H., & Levine, M. N. (2020) · JMIR Cancer · doi:10.2196/24222 · Cited by 22
Nurse navigators’ telemonitoring for cancer patients with COVID-19: a French case study
Ferrua, M., Mathivon, D., Duflot-Boukobza, A., Abbas, M., Charles, C., Barrais, A., Legendre, J., Mendes, C. G., Pons, M., Merad-Boudia, M., et al. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05968-y · Cited by 22
Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection
Awadasseid, A., Yin, Q., Wu, Y., & Zhang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111957 · Cited by 24
Kassianos, A. P., Georgiou, A., Kyprianidou, M., Lamnisos, D., Ļubenko, J., Presti, G., Squatrito, V., Constantinou, M., Nicolaou, C., Papacostas, S., et al. (2021) · Cancers · doi:10.3390/cancers13246294 · Cited by 21
Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity
Lipman, D., Safo, S. E., & Chekouo, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267047 · Cited by 22
Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
Chen, A., Zhao, W., Li, X., Sun, G., Ma, Z., Peng, L., Shi, Z., Li, X., & Yan, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840785 · Cited by 23
Covid-19 and radiotherapy: a systematic review after 2 years of pandemic
Piras, A., Venuti, V., D’Aviero, A., Cusumano, D., Pergolizzi, S., Daidone, A., & Boldrini, L. (2022) · Clinical and Translational Imaging · doi:10.1007/s40336-022-00513-9 · Cited by 22
Sehgal, K., Costa, D. B., & Rangachari, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01193 · Cited by 22
Hassan, A. M., Nogueira, L., Lin, Y.-L., Rogers, J. E., Nori‐Sarma, A., & Offodile, A. C. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01951 · Cited by 23
Prognostic Factors for Adverse Outcomes in COVID-19 Infection.
Udwadia, Z., Tripathi, A. K. R., Nanda, V., & Joshi, S. (2020) · PubMed · Cited by 21
Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis
Dumoulin, D. W., Gietema, H. A., Paats, M. S., Hendriks, L. E. L., & Cornelissen, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577696 · Cited by 21
Song, K., Gong, H., Xu, B., Dong, X., Li, L., Hu, W., Wang, Q., Xie, Z., Rao, Z., Luo, Z., et al. (2020) · Cancer · doi:10.1002/cncr.33240 · Cited by 21
COVID-19, ferrosenescence and neurodegeneration, a mini-review
Sfera, A., Osorio, C. P., Maguire, G. A., Rahman, L., Jafri, A., Cummings, M. A., & Maldonado, J. C. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110230 · Cited by 21
Fakih, R. O. E., Haroon, A., Alfraih, F. A., Al-Khabori, M. K., Alzahrani, M., Alhuraiji, A., Hamadah, A., AlJohani, N. I., Alahmari, B., Essa, M., et al. (2021) · Bone Marrow Transplantation · doi:10.1038/s41409-021-01312-y · Cited by 20
Xie, J., Qi, W., Cao, L., Tan, Y., Huang, J., Gu, X., Chen, B., Shen, P., Zhao, Y., Zhang, Y., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650766 · Cited by 21
Self-citationBiomarker based biosensors: An opportunity for diagnosis of COVID‐19
Khaksarinejad, R., Arabpour, Z., Rezakhani, L., Parvizpour, F., & Rasmi, Y. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2356 · Cited by 19
Pedrazzoli, P., Lasagna, A., Cassaniti, I., Piralla, A., Squeri, A., Bruno, R., Sacchi, P., Baldanti, F., Maïo, M. D., Beretta, G. D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101215 · Cited by 24
Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?
Geisslinger, F., Vollmar, A. M., & Bartel, K. (2020) · Pharmaceuticals · doi:10.3390/ph13070143 · Cited by 21
Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
Huang, C.-T., Chao, T., Kao, H., Pang, Y.-H., Lee, W.-H., Hsieh, C.-H., Chang, S., Huang, H., & Juan, H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05646 · Cited by 20
Cross Talk between COVID-19 and Breast Cancer
Parmar, H. S., Nayak, A., Gavel, P. K., Jha, H. C., Bhagwat, S., & Sharma, R. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210216102236 · Cited by 21
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID‐19
Gonzalez‐Lugo, J. D., Bachier‐Rodriguez, L., Goldfinger, M., Shastri, A., Sica, R. A., Gritsman, K., Mehta, V., Kabarriti, R., Goel, S., Verma, A. K., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16906 · Cited by 20
The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations
Abdihamid, O., Cai, C., Kapesa, L., & Zeng, S. (2020) · Cancer Management and Research · doi:10.2147/cmar.s272008 · Cited by 20
Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California
Wu, J. T.-Y., Kwon, D. H.-M., Glover, M. J., Henry, A. S., Wood, D., Rubin, D. L., Koshkin, V. S., Schapira, L., & Shah, S. A. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00790 · Cited by 21
Dreyer, N. A., Petruski‐Ivleva, N., Albert, L., Mohamed, D., Brinkley, E., Reynolds, M. W., & Toovey, S. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s313486 · Cited by 21
Purohit, D., Ahirwar, A. K., Sakarde, A., Asia, P., & Gopal, N. (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2020-0096 · Cited by 20
Management of Patients With Glucocorticoid-Related Diseases and COVID-19
Chifu, I. O., Detomas, M., Dischinger, U., Kimpel, O., Megerle, F., Hahner, S., Faßnacht, M., & Altieri, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.705214 · Cited by 21
Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark
Smith, H. G., Jensen, K. K., Jørgensen, L. N., & Krarup, P. (2021) · BJS Open · doi:10.1093/bjsopen/zrab108 · Cited by 23
Healthy Immunity on Preventive Medicine for Combating COVID-19
Manna, P. R., Gray, Z. C., & Reddy, P. H. (2022) · Nutrients · doi:10.3390/nu14051004 · Cited by 23
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer
Abid, M. B., Chhabra, S., Buchan, B. W., Graham, M. B., Abedin, S. M., Thapa, B., D’Souza, A., George, B., & Hamadani, M. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2020.09.002 · Cited by 20
Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
Kifle, Z. D. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100116 · Cited by 20
Arrieta, O. G., Cardona, A. F., Lara‐Mejía, L., Heredia, D., Barrón, F., Zatarain-Barrón, Z. L., Lozano, F., de Lima, V. C. C., Maldonado, F., Corona-Cruz, J. F., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103033 · Cited by 19
Wai, K. C., Xu, M. J., Lee, R. H., El‐Sayed, I. H., George, J. R., Heaton, C. M., Knott, P. D., Park, A. M., Ryan, W. R., Seth, R., et al. (2020) · Head & Neck · doi:10.1002/hed.26514 · Cited by 19
Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report
Ali, E., Badawi, M., Abdelmahmuod, E. A., Kohla, S. A. S., & Yassin, M. A. (2020) · American Journal of Case Reports · doi:10.12659/ajcr.926062 · Cited by 19
Sng, C. C. T., Wong, Y. N. S., Wu, A., Ottaviani, D., Chopra, N., Galazi, M., Benafif, S., Soosaipillai, G., Roylance, R. R., Lee, A. J. X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.595804 · Cited by 19
Turkdogan, S., Schnitman, G., Wang, T., Gotlieb, R., How, J., & Gotlieb, W. H. (2021) · JMIR Cancer · doi:10.2196/23637 · Cited by 20
Pomej, K., Scheiner, B., Hartl, L., Balcar, L., Meischl, T., Mandorfer, M., Reiberger, T., Müller, C., Trauner, M. A., & Pinter, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256544 · Cited by 19
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)
Echavarría, I., Galindo, J., Corral, J., Taín, M. P. D., Carrasco, F. H., González-Cruz, V. I., Mielgo-Rubio, X., Quintanar, T., Rivas-Corredor, C., & Pérez-Segura, P. (2022) · Clinical and Translational Oncology · doi:10.1007/s12094-022-02800-3 · Cited by 18
Beaulieu, É., Spanjaart, A. M., Roes, A., Rachet, B., Dalle, S., Kersten, M. J., Maucort‐Boulch, D., & Jalali, M. S. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03110-5 · Cited by 19
Marino, P., Touzani, R., Pakradouni, J., Soussan, P. B., & Gravis, G. (2022) · Cancers · doi:10.3390/cancers14071794 · Cited by 19
Dovey, Z., Horowitz, A., & Waingankar, N. (2023) · BJUI Compass · doi:10.1002/bco2.237 · Cited by 19
Naidoo, J., Reuss, J. E., Suresh, K. S., Feller-Kopman, D. J., Forde, P. M., Steinke, S. M., Rock, C., Johnson, D. B., Nishino, M., & Brahmer, J. R. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000984 · Cited by 19
Crolley, V. E., Hanna, D., Joharatnam‐Hogan, N., Chopra, N., Bamac, E., Desai, M., Lam, Y.-C., Dipro, S., Kanani, R., Benson, J., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920971147 · Cited by 19
Assessing patient risk from cancer and COVID-19: Managing patient distress
Klaassen, Z. W. A., & Wallis, C. J. D. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.01.023 · Cited by 19
He, C., Hua, X., Sun, S., Li, S., Wang, J., & Huang, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s300127 · Cited by 19
Self-citationBaşçı, S., Ata, N., Altuntaş, F., Yiğenoğlu, T. N., Dal, M. S., Korkmaz, S., Namdaroğlu, S., Baştürk, A., Hacıbekiroğlu, T., Doğu, M. H., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02784-y · Cited by 19
SARS‐CoV‐2 persistence in immunocompromised children
Dolan, S. A., Levy, J. M. M., Moss, A. F. D., Pearce, K., Butler, M., Jung, S. A., Dominguez, S. R., Mwangi, E., Maloney, K. W., & Rao, S. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29277 · Cited by 19
Pisapia, P., Pepe, F., Gristina, V., Mantia, M. L., Francomano, V., Russo, G., Iaccarino, A., & Galvano, A. (2021) · Mediastinum · doi:10.21037/med-21-9 · Cited by 18
Kaltofen, T., Hagemann, F., Harbeck, N., Wuerstlein, R., Kost, B. P., Burges, A., Mahner, S., & Trillsch, F. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06211-7 · Cited by 20
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris areaPreprint
Vuagnat, P., Frélaut, M., Ramtohul, T., Basse, C., Diakite, S., Noret, A., Bellesœur, A., Servois, V., Héquet, D., Laas, E., et al. (2020) · medRxiv · doi:10.1101/2020.04.30.20085928 · Cited by 19
Clinical recommendations on lung cancer management during the COVID ‐19 pandemic
Xu, Y., Liu, H., Hu, K., & Wang, M. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13498 · Cited by 18
COVID-19 and haematological malignancy: navigating a narrow strait
Rubinstein, S. M., & Warner, J. L. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30252-0 · Cited by 18
The feasibility and safety of immediate breast reconstruction in the COVID-19 era
Jallali, N., Hunter, J. E., Henry, F. P., Wood, S. H., Hogben, K. R., Al-Mufti, R., Hadjiminas, D. J., Dunne, J. A., Thiruchelvam, P. T. R., & Leff, D. R. (2020) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2020.08.044 · Cited by 18
COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center.
Adam, A. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.070 · Cited by 16
Radhakrishnan, V. S., Ovett, J., Rajendran, A., Kolluru, S., Pai, V., Gnanaguru, V., Dhanushkodi, M., Kalaiyarasi, J. P., Mehra, N., Selvarajan, G., et al. (2020) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2020.1831113 · Cited by 17
Pessina, F., Navarria, P., Bellu, L., Clerici, E., Politi, L. S., Tropeano, M. P., Simonelli, M., Fornari, M., & Scorsetti, M. (2020) · Neurosurgical FOCUS · doi:10.3171/2020.9.focus20704 · Cited by 18
Lee, R. J., Wysocki, O., Bhogal, T., Shotton, R., Tivey, A., Angelakas, A., Aung, T., Banfill, K., Baxter, M. A., Boyce, H., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2020.100005 · Cited by 18
Yao, K. A., Attai, D. J., Bleicher, R. J., Kuchta, K. M., Moran, M. S., Boughey, J. C., Wilke, L. G., Dietz, J. R., Stevens, R. E., Pesce, C. E., et al. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06101-1 · Cited by 18
Urological cancer patients receiving treatment during COVID-19: a single-centre perspective
Williams, S. T., Badri, S. E., & Hussain, S. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01263-7 · Cited by 18
Ullah, A. D., Sivapalan, L., Kocher, H. M., & Chelala, C. (2020) · Pancreatology · doi:10.1016/j.pan.2020.10.005 · Cited by 18
SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care
Alaeddini, M., & Etemad‐Moghadam, S. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.05.017 · Cited by 18
Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic
Bian, D. J. H., Sabri, S., & Abdulkarim, B. (2022) · Cancers · doi:10.3390/cancers14153598 · Cited by 21
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C
Schmitz, A. H., Wood, K. E., Burghardt, E. L., Koestner, B. P., Wendt, L. H., Badheka, A. V., & Sharathkumar, A. A. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12780 · Cited by 18
Park, Y., & Park, K. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1117369 · Cited by 20
Telemedicine in cancer care during COVID-19 pandemic: a systematic mapping study
Garavand, A., Khodaveisi, T., Aslani, N., Hosseiniravandi, M., Shams, R., & Behmanesh, A. (2023) · Health and Technology · doi:10.1007/s12553-023-00762-2 · Cited by 19
Yazdani, B., Sirous, H., Brogi, S., & Calderone, V. (2023) · Viruses · doi:10.3390/v15122291 · Cited by 20
Bennett, S., Søreide, K., Gholami, S., Pessaux, P., Teh, C. S. C., Segelov, E., Kennecke, H. F., Prenen, H., Myrehaug, S. D., Callegaro, D., et al. (2020) · Current Oncology · doi:10.3747/co.27.6785 · Cited by 18
Qian, W., Ye, Y., Zuo, L., Song, T., Xu, Q., Wang, Y., Qian, J., & Tian, Y. (2021) · Immunotherapy · doi:10.2217/imt-2021-0007 · Cited by 18
Kong, X., Qi, Y., Huang, J., Zhao, Y. W., Zhan, Y., Qin, X., Qi, Z., Atanda, A. J., Zhang, L., Fang, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.012 · Cited by 18
Self-citationÇölkesen, F., Kılınçel, O., sozen, M., Yıldız, E., Beyaz, Ş., Çölkesen, F., Aytekin, G., Koçak, M. Z., Alsancak, Y., Araz, M., et al. (2021) · Asthma Allergy Immunology · doi:10.21911/aai.651 · Cited by 20
Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
LATIF, M. B., Shukla, S., Estrada, P. M. D. R., Ribeiro, S. P., Sékaly, R., & Sharma, A. (2021) · Translational research · doi:10.1016/j.trsl.2021.12.001 · Cited by 18
Metadata
- Authors
- Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., Yu, T., Wang, L., Wang, H., Liu, Y., Chen, Y., Mei, J., Gao, X., Li, Z., Gan, L., He, C., Li, Z., Shi, Y., Qi, Y., Yang, J., Tenen, D. G., Chai, L., Mucci, L. A., Santillana, M., & Cai, H.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Wuhan Union Hospital (CN)
- Central Hospital of Wuhan (CN)
- Huanggang Central Hospital (CN)
- Guangzhou Medical University (CN)
- Tongji Hospital (CN)
- 16Department of Radiology, Hubei Cancer Hospital, Wuhan, Hubei, China.
- Hubei Cancer Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
- 19Department of Oncology, Wuhan Puren Hospital, Wuhan, Hubei, China.
- Xianning Central Hospital (CN)
- The Central Hospital of Xiao gan (CN)
- 22Department of Obstetrics and Gynecology, The People's Hospital of Huangmei, Huangmei, Hubei, China.
- Hubei University of Medicine (CN)
- Harvard University (US)
- Corresponding author
- Liu, Miao
- Santillana, Mauricio
- Cai, Hongbing
- ORCID
- Venue
- Cancer Discovery
- Published
- 2020-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 783-791
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC7309152
- OpenAlex
- W3015599879
- Cited by
- 1,589
- References
- 27
- Citations by year
- 2026: 16 · 2025: 55 · 2024: 90 · 2023: 218 · 2022: 354 · 2021: 494 · 2020: 356
- FWCI
- 128.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Discovery (publishedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (8197103302/H16)
- Singapore Ministry of Health's National Medical Research Council (MOH-STaR18nov-0002)
- NIH NHLBI (P01HL095489)
- Xiu Research Fund
- Institutional Ethics Board of Zhongnan Hospital of Wuhan University (2020029)
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- COVID-19 pandemic, SARS-CoV-2, cancer patients, disease severity, hematologic malignancies, lung cancer, metastatic cancer, radiotherapy, infection susceptibility
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Disease Outbreaks, Female, Humans, Intensive Care Units, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Respiration, Artificial, Cohort Studies, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
